These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24867785)

  • 1. Reply to Rhodes et al.
    Roberts JA; Paul SK; Akova M; Bassetti M; De Waele JJ; Dimopoulos G; Kaukonen KM; Koulenti D; Martin C; Montravers P; Rello J; Rhodes A; Starr T; Wallis SC; Lipman J
    Clin Infect Dis; 2014 Sep; 59(6):907-8. PubMed ID: 24867785
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial commentary: Are blood concentrations enough for establishing pharmacokinetic/pharmacodynamic relationships?
    Craig WA
    Clin Infect Dis; 2014 Apr; 58(8):1084-5. PubMed ID: 24470275
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes.
    Rhodes NJ; MacVane SH; Kuti JL; Scheetz MH
    Clin Infect Dis; 2014 Sep; 59(6):905-7. PubMed ID: 24867788
    [No Abstract]   [Full Text] [Related]  

  • 4. Profound underdosing of β-lactams in patients with sickle-cell disease.
    Cecchini J; Hulin A; Habibi A; Mekontso Dessap A; Razazi K
    J Antimicrob Chemother; 2018 Nov; 73(11):3211-3212. PubMed ID: 30059983
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?
    Roberts JA; Hope WW; Lipman J
    Int J Antimicrob Agents; 2010 May; 35(5):419-20. PubMed ID: 20189777
    [No Abstract]   [Full Text] [Related]  

  • 6. Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.
    Burkhardt O; Kumar V; Schmidt S; Kielstein JT; Welte T; Derendorf H
    Int J Antimicrob Agents; 2010 Jan; 35(1):96-7. PubMed ID: 19896806
    [No Abstract]   [Full Text] [Related]  

  • 7. Subtleties in practical application of prolonged infusion of β-lactam antibiotics.
    De Waele JJ; Lipman J; Carlier M; Roberts JA
    Int J Antimicrob Agents; 2015 May; 45(5):461-3. PubMed ID: 25749200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic therapy for pregnant patients].
    Mikamo H
    Nihon Naika Gakkai Zasshi; 2006 Nov; 95(11):2208-13. PubMed ID: 17168394
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.
    Grupper M; Kuti JL; Nicolau DP
    Clin Microbiol Rev; 2016 Oct; 29(4):759-72. PubMed ID: 27413094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotics: new and old drugs, rational prescription].
    de With K; Stocker H; Borde J; Kern WV
    Dtsch Med Wochenschr; 2012 Feb; 137(5):186-9. PubMed ID: 22278687
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
    Delattre IK; Taccone FS; Jacobs F; Hites M; Dugernier T; Spapen H; Laterre PF; Wallemacq PE; Van Bambeke F; Tulkens PM
    Expert Rev Anti Infect Ther; 2017 Jul; 15(7):677-688. PubMed ID: 28571493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What we know and what we want to know about beta-lactams. Pharmacokinetics and pharmacodynamics of beta lactams].
    Sörgel F; Bulitta J; Landersdorfer C
    Pharm Unserer Zeit; 2006; 35(5):438-51. PubMed ID: 17009789
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolonged β-lactam infusion for Gram-negative Infections.
    Tamma PD; Jenh AM; Milstone AM
    Pediatr Infect Dis J; 2011 Apr; 30(4):336-7. PubMed ID: 21407037
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study.
    Huttner A; Von Dach E; Renzoni A; Huttner BD; Affaticati M; Pagani L; Daali Y; Pugin J; Karmime A; Fathi M; Lew D; Harbarth S
    Int J Antimicrob Agents; 2015 Apr; 45(4):385-92. PubMed ID: 25656151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections.
    Verdier MC; Seguin P; Le Touvet B; Cady A; Mallédant Y; Tribut O
    J Antimicrob Chemother; 2011 Aug; 66(8):1934-6. PubMed ID: 21632578
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
    Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
    Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of oral beta-lactam prodrugs.
    Walstad RA
    J Chemother; 1989 Jul; 1(4 Suppl):498-9. PubMed ID: 16312502
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic antimicrobial agents for postoperative infections: appropriate use of antibiotics from the viewpoint of pharmacokinetic/pharmacodynamic theory].
    Takesue Y; Nakajima K; Wada Y; Ichiki K; Yanagi H; Ikeuchi H
    Nihon Geka Gakkai Zasshi; 2006 Sep; 107(5):224-9. PubMed ID: 17017418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented renal clearance and therapeutic monitoring of β-lactams.
    Udy AA; De Waele JJ; Lipman J
    Int J Antimicrob Agents; 2015 Apr; 45(4):331-3. PubMed ID: 25665727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
    Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
    Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.